Lv73
4980 积分 2021-08-12 加入
Aldosterone excess, blood pressure control, and kidney outcomes in chronic kidney disease: findings from the Cardiovascular and Metabolic Disease Etiology Research Center-High Risk (CMERC-HI) Study
4小时前
待确认
Aldosterone fuels the progression of cardiovascular-kidney -metabolic syndrome: focus on primary aldosteronism spectrum
4小时前
待确认
FDA approves first-in-class hypertension drug
2天前
待确认
Tezepelumab: An Anti-Thymic Stromal Lymphopoietin Monoclonal Antibody for the Treatment of Asthma
7天前
已完结
Effects of Plasma Aldosterone and Renin Concentrations With Blood Pressure Variation and Hypertension Risk in Chinese Adults: A Population-Based Hakka Biobank Study
1个月前
已完结
Unveiling novel molecules and therapeutic targets in hypertension – A narrative review
1个月前
已完结
Cross-Section of Hypertensive Molecular Signaling Pathways: Understanding Pathogenesis and Identifying Improved Drug Targets
1个月前
已完结
Why Can’t We Get There?
1个月前
已关闭
After 6 Decades of Blood Pressure Management, Why Is Achieving Control Still So Difficult?
1个月前
已关闭
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
2个月前
已完结
皖公网安备34019202002308
